Skip to main content

Lumos Pharma, Inc.

LUMODelisted Dec 12, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001126234

Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.

Q2 2024 vs. Q1 2024

How the institutions holding Lumos Pharma, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of LUMO: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders36360
Shares2.18M2.08M−98.5K (−4.5%)
Value$6.14M$4.82M−$1.32M (−21.5%)

New holders (5)

Institutions that held Lumos Pharma, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to LUMO in Q2 2024
InstitutionSharesValue% of portfolio
Atria Investments LLC10,803$25.1K0.00%
Redwood Wealth Management Group, LLC500$1.16K0.00%
International Assets Investment Management, LLC38$880.00%
Live Oak Investment Partners–$260.00%
Jones Financial Companies LLLP4$90.00%

Sold out (5)

Institutions that held Lumos Pharma, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of LUMO in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Blackstone Group Inc.78,624$221.7K
Two Sigma Advisers, LP31,900$90.0K
UBS Group AG3,733$10.5K
Group One Trading, L.P.150$423
Global Retirement Partners, LLC11$31